Hodgkin's disease risk is increased in patients with ulcerative colitis
- PMID: 10982757
- DOI: 10.1053/gast.2000.16487
Hodgkin's disease risk is increased in patients with ulcerative colitis
Abstract
Background & aims: All patients diagnosed with ulcerative colitis (UC) or Crohn's disease (CD) residing in Florence, Italy, in 1978-1992 were identified and included in a population-based study of cancer risk evaluation.
Methods: A total of 920 patients were followed up (median, 11 years), and 64 newly diagnosed malignancies were identified by linkage to the local cancer registry. Expected cases were calculated on the basis of age- and sex-specific cancer incidence rates to estimate relative risks in comparison with the general population.
Results: Overall, cancer incidence rates were not increased. A significant excess risk of Hodgkin's disease was observed among patients with UC (standardized incidence ratio, 9.3; 95% confidence interval [CI], 2.5-23.8). Respiratory tract cancers were significantly reduced to one fourth of the expected rate in patients with UC, but tended to be increased among patients with CD, who had a 50% higher risk of cancer at all sites. Only a nonsignificant, modestly increased risk of colorectal cancer was observed.
Conclusions: A strongly increased risk of Hodgkin's disease was evident in this first cancer follow-up of a representative series of patients with UC in a Mediterranean country. Two divergent risk patterns of respiratory tract cancers, possibly explained by differences in smoking habits, emerged in the 2 inflammatory bowel diseases.
Similar articles
-
Divergent patterns of total and cancer mortality in ulcerative colitis and Crohn's disease patients: the Florence IBD study 1978-2001.Gut. 2004 Sep;53(9):1309-13. doi: 10.1136/gut.2003.031476. Gut. 2004. PMID: 15306591 Free PMC article.
-
General and cancer specific mortality of a population based cohort of patients with inflammatory bowel disease: the Florence Study.Gut. 1998 Feb;42(2):175-9. doi: 10.1136/gut.42.2.175. Gut. 1998. PMID: 9536940 Free PMC article.
-
Total and cancer mortality in a cohort of ulcerative colitis and Crohn's disease patients: The Florence inflammatory bowel disease study, 1978-2010.Dig Liver Dis. 2016 Oct;48(10):1162-7. doi: 10.1016/j.dld.2016.07.008. Epub 2016 Jul 15. Dig Liver Dis. 2016. PMID: 27481588
-
The epidemiology of inflammatory bowel disease.Scand J Gastroenterol. 2015 Aug;50(8):942-51. doi: 10.3109/00365521.2015.1014407. Epub 2015 Feb 17. Scand J Gastroenterol. 2015. PMID: 25687629 Review.
-
Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease: a meta-analysis of 16 observational studies.Eur J Gastroenterol Hepatol. 2016 Apr;28(4):383-90. doi: 10.1097/MEG.0000000000000576. Eur J Gastroenterol Hepatol. 2016. PMID: 26938805 Review.
Cited by
-
Infliximab and newly diagnosed neoplasia in Crohn's disease: a multicentre matched pair study.Gut. 2006 Feb;55(2):228-33. doi: 10.1136/gut.2005.075937. Epub 2005 Aug 24. Gut. 2006. PMID: 16120759 Free PMC article.
-
Divergent patterns of total and cancer mortality in ulcerative colitis and Crohn's disease patients: the Florence IBD study 1978-2001.Gut. 2004 Sep;53(9):1309-13. doi: 10.1136/gut.2003.031476. Gut. 2004. PMID: 15306591 Free PMC article.
-
Safety of biologics in inflammatory bowel disease.Curr Treat Options Gastroenterol. 2006 Jun;9(3):221-33. doi: 10.1007/s11938-006-0041-4. Curr Treat Options Gastroenterol. 2006. PMID: 16901386
-
Hospitalization-based major comorbidity of inflammatory bowel disease in Canada.Can J Gastroenterol. 2007 Aug;21(8):507-11. doi: 10.1155/2007/924257. Can J Gastroenterol. 2007. PMID: 17703250 Free PMC article.
-
Intestinal cancer in inflammatory bowel disease: natural history and surveillance guidelines.Ann Gastroenterol. 2012;25(3):193-200. Ann Gastroenterol. 2012. PMID: 24714149 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical